Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BBLG is expected to report earnings to fall 55.81% to -18 cents per share on November 13
Q3'26
Est.
$-0.19
Q2'26
Missed
by $0.04
Q4'25
Beat
by $6.98
Q3'25
Beat
by $7.55
Q2'25
Beat
by $6.51
The last earnings report on September 02 showed earnings per share of -43 cents, missing the estimate of -38 cents. With 9.91K shares outstanding, the current market capitalization sits at 1.16M.